Journal article icon

Journal article

Rationale and clinical results of inhibiting interleukin-5 for the treatment of severe asthma

Abstract:

Severe asthma is responsible for considerable morbidity and a high proportion of the healthcare costs attributable to asthma. Management is not straightforward as the clinical, pathological and physiological features are heterogeneous and the relationships between these features are poorly understood. In recent years significant progress has been made in understanding this heterogeneity and eosinophilic asthma has emerged as a potentially clinically important phenotype because treatment with ...

Expand abstract

Actions


Access Document


Publisher copy:
10.1007/s11882-013-0379-3

Authors


Journal:
Current Allergy and Asthma Reports
Volume:
13
Issue:
5
Pages:
469-476
Publication date:
2013-10-05
DOI:
EISSN:
1534-6315
ISSN:
1529-7322
URN:
uuid:199d8259-7bb9-4d0d-8f3b-ec6a96b6be2e
Source identifiers:
435423
Local pid:
pubs:435423

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP